AVLIX | VIVAX | AVLIX / VIVAX | |
Total Expense Ratio | 0.79 | 0.17 | 465% |
Annual Report Gross Expense Ratio | 0.82 | 0.17 | 482% |
Fund Existence | 28 years | 33 years | - |
Gain YTD | 6.963 | 5.331 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 3000 | 166,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.17B | 195B | 1% |
Annual Yield % from dividends | 1.94 | 2.06 | 94% |
Returns for 1 year | 4.61 | 11.27 | 41% |
Returns for 3 years | 5.85 | 34.22 | 17% |
Returns for 5 years | 34.55 | 78.60 | 44% |
Returns for 10 years | 16.63 | 113.04 | 15% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PMDAX | 19.04 | N/A | N/A |
Principal Small-MidCap Dividend Inc A | |||
TRXCX | 11.96 | N/A | N/A |
Catalyst/MAP Global Balanced C | |||
SVXAX | 63.56 | N/A | N/A |
Smead International Value A | |||
OEGIX | 35.79 | -0.03 | -0.08% |
Invesco Discovery Mid Cap Growth R6 | |||
VSRDX | 18.95 | -0.14 | -0.73% |
VALIC Company I U.S. Socially Rspnb |